Ads
related to: biotech pharmaceuticals
Search results
When Will Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Become Profitable?
Simply Wall St. via Yahoo Finance· 2 days agoWe've put together a brief outline of industry analyst expectations for the company, its year of...
Phio Pharmaceuticals advances to next dose in cancer trial By Investing.com
Investing.com· 1 day agoPhio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company specializing in gene silencing...
Cambridge Investment Research Advisors Inc. Sells 2,003 Shares of Regeneron Pharmaceuticals, Inc....
ETF DAILY NEWS· 18 hours agoCambridge Investment Research Advisors Inc. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 19.8% during the fourth quarter, according ...
The Massive Deal That Could Send This Biotech Into A Break Out
Investor's Business Daily· 2 days agoAgios Pharmaceuticals (AGIO) agreed Tuesday to sell its 15% royalty in a brain cancer drug to...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 6 days agoIn the past six months, shares of MRNA have rallied 108.94%. (See the last biotech stock roundup...
D.C.’s Vanda Pharmaceuticals rejects acquisition offer — again - Washington Business Journal
The Business Journals· 1 day agoVanda Pharmaceuticals Inc. (NASDAQ: VNDA) has rejected an unsolicited acquisition proposal that...
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 1 day agoInsmed stock catapulted Tuesday after the biotech company's experimental lung disease treatment...
Oncocross Expands Collaboration with JW Pharmaceutical on Developing Innovative New Drugs Using AI...
Benzinga· 3 days agoOncocross, a Seoul-based AI drug discovery and development biotech, announced on May 22nd that it has signed a joint research agreement with JW Pharmaceutical< ...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 7 days agoAktis Oncology has landed a strategic collaboration with Eli Lilly (NYSE: LLY) aimed at...
2 Potentially High-Reward Growth Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 14 hours agoThis biotech, in turn, is a high-risk, high-reward vehicle. Larimar Therapeutics: A potentially...
